30.12.2014 Views

A-Textbook-of-Clinical-Pharmacology-and-Therapeutics-5th-edition

A-Textbook-of-Clinical-Pharmacology-and-Therapeutics-5th-edition

A-Textbook-of-Clinical-Pharmacology-and-Therapeutics-5th-edition

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

248 ALIMENTARY SYSTEM AND LIVER<br />

Vagal stimulation<br />

Acetylcholine<br />

Parietal cell<br />

M 1 -receptor<br />

Ca 2<br />

H <br />

Gastrin<br />

receptor<br />

Ca 2<br />

H -ATP<br />

proton pump<br />

Stomach<br />

lumen<br />

Gastrin<br />

K <br />

H 2 -receptor<br />

ATP<br />

cAMP<br />

K <br />

Histamine<br />

Cl <br />

Gastrin<br />

receptor<br />

Mast cell<br />

Histamine<br />

Figure 34.1: Mechanisms regulating hydrochloric acid secretion.<br />

ulcer recurrence <strong>and</strong> complications following successful eradication<br />

<strong>of</strong> the organism. It has been shown that the speed <strong>of</strong><br />

ulcer healing obtained with acid-suppressing agents is accelerated<br />

if H. pylori eradication is achieved concomitantly.<br />

Moreover, eradication <strong>of</strong> H. pylori infection prior to the commencement<br />

<strong>of</strong> NSAID therapy reduces the occurrence <strong>of</strong> gastro-duodenal<br />

ulcers in patients who have not had previous<br />

exposure to NSAIDs. H. pylori appears to be associated with<br />

increased risk <strong>of</strong> gastric cancer <strong>of</strong> the corpus <strong>and</strong> antrum.<br />

Key points<br />

Recommendations for eradication <strong>of</strong> Helicobacter pylori<br />

• duodenal ulcer<br />

• gastric ulcer<br />

• mucosa-associated lymphoid tissue (MALT) lymphoma<br />

• severe H. pylori gastritis.<br />

• patients requiring long-term proton-pump inhibitor<br />

treatment (risk <strong>of</strong> accelerated gastric atrophy)<br />

• blind treatment with eradication therapy is not<br />

recommended.<br />

PRINCIPLES OF MANAGEMENT<br />

The therapeutic objectives are as follows:<br />

• symptomatic relief;<br />

• promotion <strong>of</strong> ulcer healing;<br />

• prevention <strong>of</strong> recurrence, once healing has occurred;<br />

• prevention <strong>of</strong> complications.<br />

GENERAL MANAGEMENT<br />

• Stopping smoking increases the healing rate <strong>of</strong><br />

gastric ulcers <strong>and</strong> is more effective in preventing the<br />

recurrence <strong>of</strong> duodenal ulcers than H 2 -receptor<br />

antagonists.<br />

• Diet is <strong>of</strong> symptomatic importance only. Patients usually<br />

discover for themselves which foods aggravate<br />

symptoms.<br />

• Avoid ‘ulcerogenic’ drugs, including caffeine (as strong<br />

c<strong>of</strong>fee or tea), alcohol, aspirin <strong>and</strong> other NSAIDs<br />

(paracetamol is a safe minor analgesic in these cases), <strong>and</strong><br />

glucocorticosteroids.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!